Panitumumab in Cetuximab Refractory KRAS Wild-Type Colorectal Cancer

The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2010 by Massachusetts General Hospital.
Recruitment status was  Not yet recruiting
Beth Israel Deaconess Medical Center
Dana-Farber Cancer Institute
Information provided by:
Massachusetts General Hospital Identifier:
First received: February 10, 2009
Last updated: May 3, 2010
Last verified: May 2010
No Study Results Posted on for this Study
  Study Status: This study is not yet open for participant recruitment.
  Estimated Study Completion Date: March 2011
  Estimated Primary Completion Date: March 2011 (Final data collection date for primary outcome measure)
No publications provided by Massachusetts General Hospital

Publications automatically indexed to this study by Identifier (NCT Number):